F/TAF TabletsEvaluation of Single Dosing With Two F/TAF Tablets Among Healthy Volunteers

Sponsor:

Johns Hopkins University

Code:

NCT07349758

Conditions

Healthy Volunteer

HIV Prevention

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Interventions

tenofovir alafenamide [TAF] 50 mg/emtricitabine [FTC] 400mg

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-26. This information was provided to ClinicalTrials.gov by Johns Hopkins University on 2026-02-13.